Brian Smith

Join the revolution! We’re changing the way the world treats inflammation and the way the pharma industry treats humanity. Invest today → https://wefunder.com/senjam Sen-Jams Global scientists have developed a multi-indication patent and FDA-pending product for the prevention of pain and flu-like symptoms for indications not currently being addressed by the FDA OTC Drug Monograph. Its time for a stronger, more resilient world, free of side-effects and filled with living remarkably

Launched in 2020, The Main Stage provides companies with the tools to attract investors, manage relationships, and raise capital. In creating an invite-only Story Vault, The MainStage allows companies to showcase exciting content, including videos and stylistic pitch decks, to interested investors. In addition to helping tell an effective investor story, The Main Stage enables companies to send and receive investor communications, store investor information and helps a company to stay compliant while raising money.

HeartBeam, Inc. (NASDAQ: BEAT) is a medical technology company dedicated to transforming cardiac care by providing powerful insights wherever the patient is. The Company is creating the first ever cable-free 12-lead ECG capable of capturing the heart’s electrical signals from three dimensions.

Join the revolution! We’re changing the way the world treats inflammation and the way the pharma industry treats humanity. Invest today → https://wefunder.com/senjam Sen-Jams Global scientists have developed a multi-indication patent and FDA-pending product for the prevention of pain and flu-like symptoms for indications not currently being addressed by the FDA OTC Drug Monograph. Its time for a stronger, more resilient world, free of side-effects and filled with living remarkably

Launched in 2020, The Main Stage provides companies with the tools to attract investors, manage relationships, and raise capital. In creating an invite-only Story Vault, The MainStage allows companies to showcase exciting content, including videos and stylistic pitch decks, to interested investors. In addition to helping tell an effective investor story, The Main Stage enables companies to send and receive investor communications, store investor information and helps a company to stay compliant while raising money.

HeartBeam, Inc. (NASDAQ: BEAT) is a medical technology company dedicated to transforming cardiac care by providing powerful insights wherever the patient is. The Company is creating the first ever cable-free 12-lead ECG capable of capturing the heart’s electrical signals from three dimensions.

For Founders: From life-saving products to cutting-edge technology, healthcare innovation shouldn’t be capped by fundraising obstacles — but it is. We help founders tell their story to more people, find the right investors, and partner for long-term success. For Investors: Investors face their own challenges — from the need for crowdsourced feedback to expert vetting and streamlined funding opportunities. As a part of Alira Heath, were able to do more than help you raise capital. We understand that funding is only one of the many hurdles companies face. At RedCrow, we’re committed to supporting your business beyond the fundraise in ways that really matter. Join us today at www.redcrow.com Red Crow Crowd, Inc is owned by Alira Health. Securities are offered through Alira Health Transaction Services LLC (FINRA CRD No. 140203) a registered broker-dealer, a member of FINRA | SIPC. Information on all FINRA-registered broker-dealers can be found on FINRA’s BrokerCheck. All securities-related activity is conducted by Alira Health Transaction Services, located at 1 Grant St, Framingham, Massachusetts 01702. Neither RedCrow or Alira Health Transaction Services provides investment advice or makes investment recommendations on this website; nothing posted on the Site should be construed as such. No communication on this page should be construed as a recommendation for any security offered on or off this investment platform. Alternative investments are speculative, involve a high degree of risk and are not suitable for all investors and you should not invest unless you are able to sustain the risk of loss of your entire investment. Complete loss of principal is possible. Private placements are unregistered securities, considered illiquid and long-term investments. Distributions are not guaranteed. Investing in securities involves risks, and there is always the potential of losing money when you invest in securities.